-
Archives
- June 2018
- February 2018
- May 2017
- January 2017
- December 2016
- November 2016
- October 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- August 2015
- July 2015
- June 2015
- March 2015
- February 2015
- September 2014
- July 2014
- January 2014
- November 2013
- July 2013
- June 2013
- April 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- June 2012
- May 2012
- March 2012
- December 2011
- November 2011
- July 2011
- March 2011
-
Meta
Category Archives: AHPPI News
Message from Chair: Presentations from the Joint Conference of European Human Pharmacological Societies
Dear Members, I have recently returned from a very successful and interesting International meeting in France held between the French (Club Phase 1), German (AGAH), Belgian (BAPU) and UK (AHPPI),human pharmacological societies. The meeting was entitled EARLY CLINICAL UTILITY ASSESSMENT … Continue reading
New Year Message From Committee Chair
Dear Members, I just wanted to update you on what we are up to and what is planned for 2013. We had a very successful annual meeting last year and your committee is about to embark upon planning this year’s … Continue reading
ISCTM Award
The International Society for CNS Clinical Trials and Methodology (ISCTM) is looking for new investigators as potential candidates for their new award program. Interested parties can find further information by clicking below: https://isctm.org/NewInvestigator_2013
Comments Off on ISCTM Award
Phase I Accreditation Scheme Update – Deadline Extension
Following a successful meeting concerning improving the MHRA Phase 1 Accreditation Scheme on the 26th October, please click here for a summary of discussions and actions. We would appreciate your comments by the 20th January 2013 to info@ahppi.org.uk.
Comments Off on Phase I Accreditation Scheme Update – Deadline Extension
Phase I Accreditation Scheme Update – Stakeholder Meeting 26th October 2012
The AHPPI has been invited by the MHRA to participate in a stakeholder group to discuss an update to the current Phase I Accreditation Scheme on Friday 26th October. The AHPPI will be represented by Peter Dewland and Graham Ridout. Please review the documentation and … Continue reading
Comments Off on Phase I Accreditation Scheme Update – Stakeholder Meeting 26th October 2012
Personalised Medicine – will it work?
This year’s AHPPI annual conference was held on Friday 12th October 2012, titled “Personalised Medicine – will it work?”, at The Wellcome Collection Conference Centre. There were excellent speakers from organisations such as ABPI, MHRA, NHS etc. Please view the presentations here.
Comments Off on Personalised Medicine – will it work?
Response to TOPS
Please see link to letter by Richmond Pharmacology in response to the earlier TOPS article by Boyce et al. Berelowitz et al A pan-European registration system for volunteer participation is within sight
MHRA GCP Consultative Committee Meeting
The GCP inspectorate organises a GCP consultative committee with relevant interested parties, and answering any queries. For example, relating to GCP issues, GCP inspections and also parliamentary questions. The GCP Inspectorate holds symposia every year, in which updates from the … Continue reading
Comments Off on MHRA GCP Consultative Committee Meeting
New publication on TOPS
Please see recent publication on TOPS Boyce et al. TOPS an internet-based system to prevent healthy subjects from over-volunteering for clinical trials. EJCP 2012 copy
New AHPPI Committee
Following recent nominations there is a new committee. Malcolm stepped down as chair but John Kelly, Corinthia Joseph, Ulrike Lorch, Mike Hammond and Peter Dewland were returned for another term of office. A new member is welcomed in the form … Continue reading